Atlas Trials

Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03272802 · UNKNOWN

Trial details

NCT number
NCT03272802
Sponsor
Isfahan University of Medical Sciences
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Neuromuscular Diseases
Start date
2017-03-16
Primary completion
2019-03-16
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.